•

Peter Kim

News / Photos

Quotes

Wiki

Auto Industry Showcases Vehicles at the North American International Auto Show in Detroit, Michigan

General Motors Chairman and CEO Rick Wagoner (R) acknowledges LG Chem CEO Peter Kim during a press event at the North American International Auto Show at the Cobo Center on January 12, 2009 in Detroit, Michigan. GM announced Friday that it will manufacture its own battery packs for the Chevy Volt in the United States and that it has selected LG Chem of Korea to provide the lithium ion cells for the batteries. (UPI Photo/Brian Kersey)

License photo

Enlarge

UPI Related News

Math and medicine might cure cancer

COLLEGE PARK, Md., Aug. 5 (UPI) -- U.S.-led scientists say they've used math and medicine to demonstrate how the two disciplines, when combined, might lead to a cure for cancer.

FDA pans Merck's new pain pill

WASHINGTON, April 13 (UPI) -- The U.S. Food and Drug Administration has rejected Merck's bid to sell the pain medication Arcoxia in the United States.

Merck admits Vioxx study mistake

WHITEHOUSE STATION, N.J., May 31 (UPI) -- Merck & Co. said it made a mistake in reporting that the now-withdrawn arthritis drug Vioxx caused heart problems only after 18 months of use, a report said. The admission undermines Merck's main defense against at least 11,500 lawsuits filed against it f

Blog buzz makes for free film advertising

WASHINGTON, May 31 (UPI) -- If you've seen any billboard ads or television commercials in the last month, you might be familiar with "Mission: Impossible 3" and "X-Men: The Last Stand." Both films used costly marketing strategies to raise public awareness.

Merck defends Vioxx research

WASHINGTON, Oct. 13 (UPI) -- Merck & Co. Wednesday defended its clinical research on Vioxx and said it withdrew the arthritis drug from the market as soon as data showed a safety hazard.

Merck issues worldwide recall of Vioxx

NEW YORK, Sept. 30 (UPI) -- Drug giant Merck said Thursday it is voluntarily withdrawing Vioxx, its popular arthritis and pain drug, from the market in response to studies linking long-term use to increased risk of heart attack and stroke.

HealthBiz: Vioxx decision impact unclear

WASHINGTON, Sept. 30 (UPI) -- Merck's decision to pull Vioxx from the market raises concerns about the Cox 2 inhibitor drug class, the head of CMS says science helps him bridge politics and policy, and other health business news.

Alcohol gels reduce hospital infections

SAN DIEGO, Sept. 28 (UPI) -- Researchers said Saturday that having dispensers of alcohol-based hand rubs in every hospital room significantly reduces the transmission of multi-drug resistant killer microbes that cause potentially fatal infections.

1 of 1 Prev | Next

Related Topics